dengue
DENGUE

Dengue infection is caused by the dengue virus that belongs to the family Flaviviridae. It is generally self-limiting and rarely fatal.
There are 4 serotypes (DEN-1, DEN-2, DEN-3, DEN-4). Infection w/ dengue serotype confers lifetime protective immunity to that specific serotype; cross-protection for other serotypes is only short-term.
It is transmitted to humans through the bites of infected Aedes mosquitoes. It is primarily transmitted by female Aedes aegypti, a tropical and subtropical species.Humans & monkeys are the amplifying hosts after the mosquito bite.
After 4-10 days of incubation period, illness begins immediately.
The acute phase of illness lasts for 3-7 days, but the convalescent phase may be prolonged for a week and may be associated with weakness and depression especially in adults.

Prevention

  • Preventing or reducing the transmission of dengue virus is dependent on controlling mosquito vectors or disturbing human-vector contact
  • Vaccination against dengue viruses are currently being developed, with promising results

Methods of Vector Control

  • Methods to control transmission should target habitats of immature & adult stages of A aegypti, one of the most efficient vectors for arboviruses, in the household & places where human-vector contact occurs
    • These mosquitoes mostly stay within 100 meters from where they emerged, & feeds mainly during daylight hours

Environmental Management

  • Controlling mosquito vectors are achieved mainly by eradicating container habitats that are favorable oviposition sites & development of aquatic stages through prevention of access to containers or emptying & cleaning them regularly & by using insecticides or biological control agents to kill developing stages of adult vectors
  • Mosquito screens on windows or doors, mosquito nets, & clothing that covers the arms and legs may be used while sleeping during daytime to decrease human-vector contact

Chemical Control

  • Larvicides should be done as complementary to environmental management 
  • Adulticides are used to target adult vectors which is applied either as surface treatments or as space treatments
  • Individual & household protection are advised to minimize exposure of skin & be protected from bites of dengue vectors during their active hours
    • Repellents that contain DEET (N, N-diethyl-3-methylbenzamide), IR3535 (3-[N-acetyl-N-butyl]-aminopropionic acid ethyl ester), or Icaridin (1- piperidinecarboxylic acid-2-(2-hydroxyethyl)-1-methylpropylester) may be applied to skin or to clothes; Citronella-based repellents may also be considered
    • Mosquito nets that are insecticide-treated, insecticide aerosol products, or mosquito coils may also help

Vaccination

  • Due to the immunopathological component in dengue pathogenesis, development of a dengue vaccine focuses on the creation of a tetravalent vaccine that will provide long-term protection against all virus serotypes
  • The first dengue vaccine developed, CYD-TDV, is being reviewed by the World Health Organization (WHO) Strategic Advisory Group of Experts (SAGE) on Immunization
    • CYD-TDV is a live recombinant tetravalent dengue vaccine that will be used in individuals aged 9-45 years residing in endemic areas
    • Data from the 2 pivotal phase III clinical studies showed that CYD-TDV given on a 3-dose series on a 0/6/12 month schedule has a good safety profile with secondary analysis demonstrating efficacy against the four dengue serotypes & protection from severe disease & hospitalization
    • Recently, it was approved in few countries (eg Brazil, Mexico & Philippines) for prevention of dengue
  • Other vaccines under clinical trial evaluation include subunit, deoxyribonucleic acid (DNA) & purified inactivated as well as other live-attenuated vaccines
    • Additional vaccines under preclinical study evaluation are the virus-vectored & VLP-based vaccines
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Infectious Diseases - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
13 Oct 2017
Use of systemic antibiotics, in conjunction with performance of incision and drainage, in the management of paediatric acute skin and soft tissue infection (SSTI) appears to reduce Staphylococcus aureus colonization and the likelihood of infection recurrence, a prospective study has found.
12 Oct 2017
Retreatment with ledipasvir and sofosbuvir with add-on ribavirin appears to be effective and well tolerated in genotype 1 hepatitis C virus (HCV)-infected patients who have failed to respond to daclatasvir/asunaprevir combination therapy, according to a study.
5 days ago
Excessive intake of the mineral manganese can be toxic to the heart, according to a new study.